Health
Researchers show a simple way to protect transplanted islets from rejection – News-Medical.Net
Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer…
Reviewed by Emily Henderson, B.Sc.Oct 22 2020
Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer swings in the levels of glucose in the blood that impact life expectancy and increase risks of cardiovascular disease, neuropathies and kidney failure.
One therapy is promising — transplanting pancreatic islets from cadavers. But this requires immunosuppression, and reactivated autoimmunity…
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year